Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings Corporation has revised its consolidated performance forecast for fiscal 2025, anticipating a significant increase in profit attributable to owners of the parent due to extraordinary profit from the sale of investment securities. This adjustment reflects a strategic move to reduce cross-shareholdings, potentially enhancing the company’s financial performance and positioning in the healthcare industry.
The most recent analyst rating on (JP:2784) stock is a Buy with a Yen2438.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
The Alfresa Group is a leader in the Japanese healthcare industry, focusing on ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, operating dispensing pharmacies, and regenerative medicine-related business. Alfresa Holdings Corporation reported consolidated revenue of ¥2.9 trillion for the fiscal year ended March 31, 2025.
Average Trading Volume: 393,905
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen415.5B
Find detailed analytics on 2784 stock on TipRanks’ Stock Analysis page.